.svg)
.webp)
Learn what RTSM, IRT, and IWRS mean, how they differ, and why they are essential for clinical trial randomization and supply management.
RTSM refers to the clinical trial functions that manage randomization and trial supply. IRT is the technology often used to deliver those functions. IWRS is an earlier, web-based form of interactive response technology that is still referenced in some legacy contexts.
This FAQ is designed for the broad set of teams that plan, run, analyze, and support clinical trials, including study teams, data and digital teams, supply and operations, quality and compliance, IT, and leadership. It explains how Randomization and Trial Supply Management (RTSM) and Interactive Response Technology (IRT) work, how the terms differ, and which capabilities matter most as trials become more adaptive, global, and complex.
Whether you are learning about RTSM and IRT for the first time, comparing RTSM software vendors, or modernizing randomization and clinical trial supply management across a portfolio, this page provides a practical foundation while reflecting how modern platforms are applied in real study operations.
RTSM stands for Randomization and Trial Supply Management. In clinical trials, RTSM is a centralized randomization and clinical trial supply management system used to control how participants are assigned to treatment arms and how investigational product is managed, distributed, and tracked throughout the study lifecycle.
An RTSM platform brings together two essential trial functions:
By automating these workflows, RTSM helps preserve study integrity, reduce operational risk, and support compliance expectations, including Good Clinical Practice (GCP) and 21 CFR Part 11 requirements. Modern RTSM platforms, including Endpoint RTSM within the Elosity platform, are designed to scale across Phase 1, Phase 2, and Phase 3 trials, adaptive trial designs, and master protocols.
Learn more about Endpoint RTSM →An RTSM system serves as an operational backbone for a clinical trial by coordinating patient enrollment, randomization, cohort management, and investigational product logistics in real time. While capabilities vary by RTSM vendor, modern RTSM software commonly supports:
As trials become more global, decentralized, and complex, sponsors increasingly seek RTSM platforms that can be rapidly configured, validated, integrated, and scaled without adding unnecessary operational burden. This approach underpins modern, cloud-based RTSM platforms such as Elosity.
IRT stands for Interactive Response Technology. IRT refers to the technology platform that enables real-time interaction between clinical trial sites, depots, sponsors, CROs, and centralized study systems. IRT provides the interface, infrastructure, and workflows through which randomization, drug supply tracking, and clinical supply chain activities are executed.
Historically, IRT evolved from earlier systems, including IVRS, Interactive Voice Response Systems, IWRS, Interactive Web Response Systems, and IxRS, a hybrid term that can refer to both voice and web modalities.
Today, IRT platforms are typically modern, cloud-based systems that deliver RTSM functionality, integrate with EDC, eCOA, eConsent, and CTMS, and support more specialized trial requirements, including biologics, cold-chain therapies, and cell and gene therapy trials.
RTSM and IRT are closely related, and the terms are often used interchangeably in clinical trial technology discussions. As covered above, RTSM describes the functional scope (randomization and trial supply management), while IRT describes the technology platform used to deliver that scope.
Because most modern IRT systems deliver RTSM functionality, sponsors, CROs, procurement teams, and vendors may use RTSM, IRT, and IxRS in overlapping ways. For website and search purposes, using both RTSM and IRT language helps match how buyers actually research these solutions.
The comparison table above breaks down how these terms relate: RTSM is the operational capability, IRT is the technology platform that delivers it, and IWRS and IVRS are earlier, narrower forms of that technology, web-based and phone-based respectively, still referenced in legacy contexts.
For modern clinical trial technology evaluation, most solutions are best described as RTSM platforms delivered through IRT technology. This phrasing captures both the operational function sponsors need and the technology category many buyers still search for.
RTSM plays a critical role in protecting scientific validity, regulatory compliance, patient safety, and operational efficiency. As a clinical trial randomization system and clinical supply management platform, RTSM helps:
As adaptive trial designs and real-time enrollment models become more common, RTSM is increasingly viewed as strategic infrastructure rather than a standalone study tool.
RTSM is used across Phase 1, Phase 2, Phase 3, and post-marketing studies. It is especially valuable for clinical trials with complex randomization, drug supply, or cohort requirements, including:
Platforms such as Elosity are designed to support this breadth without requiring separate systems for different study types.
RTSM platforms function as clinical trial randomization software by executing protocol-defined randomization schemes such as simple, block, stratified, dynamic, and adaptive randomization. The system automates patient randomization while applying eligibility criteria and stratification factors consistently across sites.
For blinded studies, RTSM also helps maintain treatment assignment controls so the right users can access the right information while preserving blinding integrity.
RTSM manages the lifecycle of investigational product as a centralized clinical supply management system. This includes packaging strategy, labeling, shipment, dispensing, returns, reconciliation, expiry management, and real-time inventory tracking for clinical trials.
Advanced RTSM platforms help sponsors reduce clinical trial supply waste while ensuring the right drug is available at the right site, cohort, and time.
Explore trial supply management with Endpoint →Modern RTSM and IRT platforms are built to integrate via APIs with EDC, eCOA, eConsent, CTMS, clinical data platforms, and other systems in the clinical technology ecosystem. These integrations can support real-time enrollment workflows, reduce reconciliation effort, and create a more connected data and supply chain environment.
Endpoint's approach emphasizes interoperability so RTSM functions as part of an integrated ecosystem rather than an isolated application.
RTSM and EDC support different parts of a clinical trial. RTSM focuses on randomization, treatment assignment, trial supply management, dispensing, inventory, and drug accountability. EDC, or electronic data capture, is used to collect and manage clinical trial data from sites and study forms.
The two systems often need to work together. For example, enrollment or eligibility data may inform RTSM randomization, while treatment assignment or dispensing events may need to be reconciled with clinical data workflows.
RTSM and CTMS also serve different operational needs. RTSM manages randomization and investigational product workflows at the study, site, depot, and patient level. CTMS, or clinical trial management system, is typically used to manage broader trial operations such as study milestones, site management, monitoring activities, and operational oversight.
Integration between RTSM and CTMS can help sponsors and CROs maintain better visibility across study execution, especially when operational status, enrollment activity, and supply needs are closely connected.
Yes. Modern RTSM platforms can support adaptive clinical trials when they are designed to accommodate protocol-specific rules, cohort changes, dose escalation, treatment arm changes, and evolving randomization logic. This is especially important in oncology, master protocol, basket, and umbrella trial designs.
For adaptive studies, sponsors should look for an RTSM platform that can be configured and validated efficiently, support controlled changes, preserve blinding requirements, and maintain clear audit trails across randomization and supply workflows.
When comparing IRT vendors or RTSM providers, sponsors and CROs typically evaluate both technology fit and operational partnership. Important criteria include:
Rather than focusing only on search terms like "top IRT vendors" or "best RTSM providers," many organizations prioritize platform flexibility, compliance readiness, implementation quality, and the ability to support increasingly complex study portfolios.
RTSM stands for Randomization and Trial Supply Management. In clinical trials, RTSM is a centralized randomization and clinical trial supply management system used to control how participants are assigned to treatment arms and how investigational product is managed, distributed, and tracked throughout the study lifecycle.
An RTSM platform brings together two essential trial functions:
By automating these workflows, RTSM helps preserve study integrity, reduce operational risk, and support compliance expectations, including Good Clinical Practice (GCP) and 21 CFR Part 11 requirements. Modern RTSM platforms, including Endpoint RTSM within the Elosity platform, are designed to scale across Phase 1, Phase 2, and Phase 3 trials, adaptive trial designs, and master protocols.
Learn more about Endpoint RTSM →An RTSM system serves as an operational backbone for a clinical trial by coordinating patient enrollment, randomization, cohort management, and investigational product logistics in real time. While capabilities vary by RTSM vendor, modern RTSM software commonly supports:
As trials become more global, decentralized, and complex, sponsors increasingly seek RTSM platforms that can be rapidly configured, validated, integrated, and scaled without adding unnecessary operational burden. This approach underpins modern, cloud-based RTSM platforms such as Elosity.
IRT stands for Interactive Response Technology. IRT refers to the technology platform that enables real-time interaction between clinical trial sites, depots, sponsors, CROs, and centralized study systems. IRT provides the interface, infrastructure, and workflows through which randomization, drug supply tracking, and clinical supply chain activities are executed.
Historically, IRT evolved from earlier systems, including IVRS, Interactive Voice Response Systems, IWRS, Interactive Web Response Systems, and IxRS, a hybrid term that can refer to both voice and web modalities.
Today, IRT platforms are typically modern, cloud-based systems that deliver RTSM functionality, integrate with EDC, eCOA, eConsent, and CTMS, and support more specialized trial requirements, including biologics, cold-chain therapies, and cell and gene therapy trials.
RTSM and IRT are closely related, and the terms are often used interchangeably in clinical trial technology discussions. As covered above, RTSM describes the functional scope (randomization and trial supply management), while IRT describes the technology platform used to deliver that scope.
Because most modern IRT systems deliver RTSM functionality, sponsors, CROs, procurement teams, and vendors may use RTSM, IRT, and IxRS in overlapping ways. For website and search purposes, using both RTSM and IRT language helps match how buyers actually research these solutions.
The comparison table above breaks down how these terms relate: RTSM is the operational capability, IRT is the technology platform that delivers it, and IWRS and IVRS are earlier, narrower forms of that technology, web-based and phone-based respectively, still referenced in legacy contexts.
For modern clinical trial technology evaluation, most solutions are best described as RTSM platforms delivered through IRT technology. This phrasing captures both the operational function sponsors need and the technology category many buyers still search for.
RTSM plays a critical role in protecting scientific validity, regulatory compliance, patient safety, and operational efficiency. As a clinical trial randomization system and clinical supply management platform, RTSM helps:
As adaptive trial designs and real-time enrollment models become more common, RTSM is increasingly viewed as strategic infrastructure rather than a standalone study tool.
RTSM is used across Phase 1, Phase 2, Phase 3, and post-marketing studies. It is especially valuable for clinical trials with complex randomization, drug supply, or cohort requirements, including:
Platforms such as Elosity are designed to support this breadth without requiring separate systems for different study types.
RTSM platforms function as clinical trial randomization software by executing protocol-defined randomization schemes such as simple, block, stratified, dynamic, and adaptive randomization. The system automates patient randomization while applying eligibility criteria and stratification factors consistently across sites.
For blinded studies, RTSM also helps maintain treatment assignment controls so the right users can access the right information while preserving blinding integrity.
RTSM manages the lifecycle of investigational product as a centralized clinical supply management system. This includes packaging strategy, labeling, shipment, dispensing, returns, reconciliation, expiry management, and real-time inventory tracking for clinical trials.
Advanced RTSM platforms help sponsors reduce clinical trial supply waste while ensuring the right drug is available at the right site, cohort, and time.
Explore trial supply management with Endpoint →Modern RTSM and IRT platforms are built to integrate via APIs with EDC, eCOA, eConsent, CTMS, clinical data platforms, and other systems in the clinical technology ecosystem. These integrations can support real-time enrollment workflows, reduce reconciliation effort, and create a more connected data and supply chain environment.
Endpoint's approach emphasizes interoperability so RTSM functions as part of an integrated ecosystem rather than an isolated application.
RTSM and EDC support different parts of a clinical trial. RTSM focuses on randomization, treatment assignment, trial supply management, dispensing, inventory, and drug accountability. EDC, or electronic data capture, is used to collect and manage clinical trial data from sites and study forms.
The two systems often need to work together. For example, enrollment or eligibility data may inform RTSM randomization, while treatment assignment or dispensing events may need to be reconciled with clinical data workflows.
RTSM and CTMS also serve different operational needs. RTSM manages randomization and investigational product workflows at the study, site, depot, and patient level. CTMS, or clinical trial management system, is typically used to manage broader trial operations such as study milestones, site management, monitoring activities, and operational oversight.
Integration between RTSM and CTMS can help sponsors and CROs maintain better visibility across study execution, especially when operational status, enrollment activity, and supply needs are closely connected.
Yes. Modern RTSM platforms can support adaptive clinical trials when they are designed to accommodate protocol-specific rules, cohort changes, dose escalation, treatment arm changes, and evolving randomization logic. This is especially important in oncology, master protocol, basket, and umbrella trial designs.
For adaptive studies, sponsors should look for an RTSM platform that can be configured and validated efficiently, support controlled changes, preserve blinding requirements, and maintain clear audit trails across randomization and supply workflows.
When comparing IRT vendors or RTSM providers, sponsors and CROs typically evaluate both technology fit and operational partnership. Important criteria include:
Rather than focusing only on search terms like "top IRT vendors" or "best RTSM providers," many organizations prioritize platform flexibility, compliance readiness, implementation quality, and the ability to support increasingly complex study portfolios.
Endpoint brings RTSM-first expertise, configurable platform technology, clinical supply visibility, and integration-minded execution together through Elosity and Pulse, helping study teams support complex randomization and supply needs without unnecessary operational burden.
Endpoint supports RTSM needs through flexible, enterprise-grade IRT and RTSM solutions designed for the full spectrum of clinical trial stakeholders, from study teams and data managers to clinical supply, operations, quality, IT, and executive leadership.
Through Elosity and Pulse, Endpoint provides configurable RTSM platforms that support robust randomization, end-to-end clinical supply management, real-time visibility, and seamless integration across the clinical ecosystem. This connected approach is especially relevant as sponsors and CROs manage more adaptive protocols, complex supply strategies, and portfolio-level planning demands.
Endpoint is positioned around the operational realities of randomization and trial supply, not generic clinical technology alone.
Supports different trial designs, organizational models, and portfolio strategies without forcing every study into the same workflow.
Helps teams connect randomization, inventory, dispensing, resupply, expiry, and accountability activities.
Relevant for adaptive studies, oncology cohorts, master protocols, biologics, cold-chain models, and global trials.
Designed to integrate across the clinical technology stack rather than operate as an isolated point solution.
Creates a stronger story around RTSM execution, clinical supply planning, real-time visibility, and portfolio-level decision support.
Endpoint delivers flexible RTSM and IRT solutions designed to support the full spectrum of clinical trial stakeholders, including study teams, clinical supply teams, data managers, operations, quality, IT, and leadership. Endpoint's RTSM offerings are built to adapt to different trial designs, organizational models, and development strategies while helping teams reduce complexity across randomization and supply workflows.
Whether you are running early-phase studies, global late-phase trials, adaptive protocols, or complex supply models, Endpoint offers scalable solutions to support RTSM requirements today and as your portfolio evolves.
Learn how Endpoint can support your RTSM strategy →